InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Burrell Terry-Ann, Chief Financial Officer. Director active across 2 companies, notably Beam Therapeutics Inc.. Cumulatively, 13 filings have been logged. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
018,145 shares0
Class A Common Stock
SEC:0001209191-22-037631:0·
01,788 shares0
Class A Common Stock
SEC:0001209191-22-023316:0·
015,000 shares0
Common Stock
SEC:0000899243-22-013485:0·
0763 shares0
Class A Common Stock
SEC:0001209191-22-002050·
0763 shares0
Class A Common Stock
SEC:0001209191-22-002050:0·
0629 shares0
Class A Common Stock
SEC:0001209191-21-059745·
0629 shares0
Class A Common Stock
SEC:0001209191-21-059745:0·
0382 shares0
Class A Common Stock
SEC:0001209191-21-045551·
0382 shares0
Class A Common Stock
SEC:0001209191-21-045551:0·
€346,13130,000 shares@ €11.53770.012% mcap40.1% of flow
Common Stock
SEC:0000899243-21-027313·
€346,13130,000 shares@ €11.53770.012% mcap20.1% of flow
Common Stock
SEC:0000899243-21-027313:0·
€516,05745,000 shares@ €11.46790.018% mcap59.9% of flow
Common Stock
SEC:0000899243-21-026779·
€516,05745,000 shares@ €11.46790.018% mcap29.9% of flow
Common Stock
SEC:0000899243-21-026779:0·
13 of 13 declarations
About Burrell Terry-Ann
Terry-Ann Burrell serves as Chief Financial Officer and Board Member at Beam Therapeutics Inc. and RECURSION PHARMACEUTICALS, INC. She is responsible for strategic financial management and overseeing the financial operations of the companies. Her expertise in finance is crucial for the growth and sustainability of the organizations.
